Effective Board and Committee Leadership | Women in the Boardroom

Recorded Webinar

Effective Board and Committee Leadership

Effective Board Leadership: The Role of Board & Committee Chairs Effective board and committee leadership are keys to the success of the board in fulfilling its governance duties. Our program will focus on the elements that go into effective board and committee leadership, including cultivating the right leadership dynamic, selection of board and committee chairs, interplay between committees and the board, and between the board and management, and measuring the effectiveness in board and committee leadership. 


Howard Brod Brownstein, Jan Berger, MD, MJ, Steven Khadavi

Date & Time

December 16, 2020
12:00 PM ET


Register with Promo Code



Individual & Corporate Members, please use your promo code to register complimentary. Cost for non-members to register is $50. To become a member, click here. The recording will be emailed to you after purchase.

About the Speakers

Howard Brod Brownstein

President of Brownstein Corporation

Howard Brod Brownstein, CTP, is a nationally-known turnaround and restructuring professional, and regularly provides programs for Women in the Boardroom. He is President of Brownstein Corporation, which provides turnaround management and advisory services, as well as investment banking, fiduciary services, litigation consulting, investigations and valuation services. He regularly serves on the boards of directors of public and private companies, and currently serves on the boards of: P&F Industries (Nasdaq: PFIN) where he chairs the Nominating/Governance and Strategic Planning & Risk Assessment Committees, Renew Financial, where he serves as chair of the Risk Committee, and Merakey, a nonprofit with over 10,000 employees. He is a Certified Turnaround Professional, and also an NACD Board Leadership Fellow and Immediate Past President and Board Chair of the NACD Philadelphia Chapter. He has authored ninety articles and textbook chapters, is a Contributing Editor at two publications, and is a regular guest-lecturer at Harvard Business School, Wharton, NYU and elsewhere. He received JD and MBA degrees at Harvard, and B.S. (Wharton) and B.A. degrees from the University of Pennsylvania.

Jan Berger, MD, MJ

CEO, Health Intelligence Partners

Jan is a tri-sector healthcare executive that has proven results as a senior executive in the three sectors of private, public and government services over the last 30 years. In 2009 Jan founded Health Intelligence Partners as a health care consultancy that blends more than thirty years of business and clinical experience. Health Intelligence Partners has a global focus (engagements in 14 countries with both Health Organizations and National Ministries of Health), working with clients on areas of growth including short-term and long-term business strategies and solutions. Health Intelligence Partners helps clients to navigate the intersection of strategy and operations within both the healthcare and consumer goods and services environment in order to identify and articulate value opportunities.

Prior to founding Health Intelligence Partners, Jan served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark. During that time, she was a corporate officer and on the executive team with P & L (500 million-dollar business unit), operations and strategic experience. Jan also lead Caremark’s Medicare Part D development and was the clinical lead for CVS Caremark’s M & A activity. During this time, Jan developed an expertise in both healthcare and retail consumer behavior. Before going to CVS Caremark, Jan had 15 years’ experience in healthcare administration within the health plan and academic arenas and lead operations for two population health companies.

As a veteran healthcare executive, Jan’s leadership has delivered results in a variety of settings. Jan offers her experiences and insights through her consulting agency as well as through her participation on healthcare and consumer product boards. She presently sits on healthcare focused boards including, GNS Healthcare (Lead Independent Board Member, Vice Chair of the Board, Chair; Governance/Compensation/Nomination Committee, M&A/Strategy Committee), Cambia Health Solutions (Audit & Compliance Committee, Consumer Engagement Committee, Health Services Committee), Tabula Rasa (Nominations, Compensation, Governance), UCB Pharmaceuticals and Voluntis Health Care (Chair, M&A/Strategy Committee, Nomination and Renumeration Committee). Jan’s consumer focused boards have included Savor Health, Care Heroes and Whiskerdocs. Jan previous board experience includes; Care Core National (Committees: Audit and Finance Committee, Compensation, Search, M&A and Strategic Directions), AccentCare (Chair; Compliance Committee, Compensation Committee), Qliance and Rx-Ante. She also sits on numerous business and healthcare advisory boards.

As the author of the books “Leveraging Health”, “Thirteen Common Pitfalls in Consumer Engagement”, “We Don’t Talk Anymore: A Consumer’s Guide to Connecting with their Doctor” and “Medical Liability for Pediatricians”, the past Editor in Chief of American Journal of Pharmacy Benefit and on the editorial boards of a number of healthcare journals, Jan is considered a national health care thought leader. Jan speaks and writes on a broad range of healthcare and pharmaceutical services issues.

Jan holds a Doctor of Medicine degree, a master’s in jurisprudence from Loyola University in Chicago, and a Certificate in Healthcare Business Administration from University of South Florida. Jan is an assistant professor at Northwestern University School of Medicine and School of Communication in Chicago, Illinois where she teaches the Engaging the Consumer in Health course.

Steven Khadavi

Managing Partner of Troutman Pepper

Steven is the managing partner of the New York offices of Troutman Pepper. He has more than two decades of experience in corporate finance and securities law, as well as mergers and acquisitions. He counsels public and private companies on complex securities matters. He regularly advises boards of directors and special committees on issues of corporate governance and fiduciary duties. He has substantial experience advising underwriters and issuers in a wide range of debt and equity financing transactions, including SEC-registered offerings, private placements, debt tender offers, consent solicitations and exchange offers. He also counsels investment banks serving as financial advisors to deliver fairness and solvency opinions. Steven represents clients in the United States and abroad in various sectors, including telecommunications, health care and consumer products. He also advises Israeli clients operating in the U.S. and companies and investors doing business in Israel.

Related Content